Chemical structure of molecule CC-90001

oral JNK2 kinase inhibitor

Ph. II candidate for pulmonary fibrosis

from HTS and SBDD

Journal of Medicinal Chemistry

Celgene (Bristol Myers Squibb), San Diego, CA

CC-90001 was nominated by reviewer Christian Kuttruff. CC-90001 is a JNK (c-Jun N-Terminal Kinase) inhibitor and a Phase II clinical candidate for idiopathic pulmonary fibrosis (NCT03142191). Christian says, “Preclinical…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.